CALL FOR ABSTRACTS '20 yrs of alpha-synuclein in Parkinson's Disease & related synucleinopathies: from the bedside to the bench and back to the patient', 7-9 September 2017, Athens, Greece

view it online
 

20 years of alpha-synuclein in parkinson's disease & related synucleinopathies

Synuclein_Meeting_2017
The Hellenic Society for Neuroscience (H.S.N.) and the Attica Institute of Neurological Sciences (A.I.N.S.) are organizing the upcoming Meeting entitled '20 years of alpha- synuclein in Parkinson's Disease & related synucleinopathies: from the bedside to the bench and back to the patient' , which will take place at the Mare Nostrum hotel, located in Vravrona, Athens, GREECE

ABSTRACT SUBMISSION
The Organizing Committee invites all interested parties to submit abstracts of their work for oral or poster presentation.Abstracts must be submitted by 31 MARCH 2017 at the latest.

AWARDS
Following an evaluation by members of the Abstract Evaluation Committee, some abstracts will be selected for an award. These abstracts will be presented as ORAL PRESENTATIONS in the main Scientific Program. These awards will be used to help defray expenses associated with conference attendance of the presenting author. Award receipients will be selected based on the quality of science of the abstract and the relevance of the abstract to the conference topic. Only one award per lab will be allocated. Preference will be given to junior scientists (PhD students or post-docs) as awardees. Status of junior scientist for the presenting author should be indicated in the submission.

GUIDELINES  &  ABSTRACT SUBMISSION FORM
All the  Guidelines regarding the format for the Abstract submission, as well as the Abstract Submission Form can be reached at the Meeting website www.synuclein2017.org
 
read more
---
SCIENTIFIC PROGRAM
The meeting is a continuation of the tradition of biennial alpha-synuclein-related meetings that have been held for more than 10 years, celebrates the 20-year anniversary of the discovery of the link of the alpha-synuclein gene to familial Parkinson’s Disease (PD) and of the presence of alpha-synuclein as the main constituent of Lewy Bodies that characterize PD. Over this period of time, insights that have emerged through clinical and genetic studies, basic research in cellular and animal models, and neuropathological observations have led to the point where clinical trials targeting alpha-synuclein as a treatment for PD and related synucleinopathies are being planned and even implemented. The meeting will present the latest developments in clinical, biomarker, imaging and genetic studies in cohorts of patients afflicted with synucleinopathies, in the basic biology of alpha-synuclein, in experimental therapeutics primarily in animal models, and in emerging and ongoing clinical trials. Special attention will be devoted to ongoing studies in descendents of the original Kontursi kindred. There will also be a special session devoted to alpha-synuclein propagation, as an example of the unifying hypothesis of spreading in neurodegenerative diseases. Each session will integrate clinicians and basic scientists, so that fresh insights and a global understanding of the pathological conditions may emerge, while, at the same time, providing a rich and interactive teaching experience for the audience. The setting will encourage interaction, exchange of ideas and networking opportunities among all participants. The core meeting will be preceded by a half-day workshop on clinical aspects of synucleinopathies, culminating in an opening lecture by Dr. Stanley Fahn on the 50 year anniversary of dopamine supplementation therapy in PD.

read more
---
REGISTRATION 
To consider a Registration as confirmed and valid, all participants must submit a registration form through the  Meeting’s website and pay the appropriate registration fee (co-authors on abstracts do not need to register unless they plan to participate in the meeting). If you plan to submit an abstract, registration at the meeting is necessary.
The registration fee includes:
-  access to the meeting venue (regardless of attendance of one or more days),
-  conference material,
-  coffee breaks,
-  Certificate accredited with CME-CPD Credits, by the Panhellenic Medical Association

read more

ACCOMMODATION 
All participants of the Scientific Meeting will be accommodated in the Meeting´s Hotel ´MARE NOSTRUM´ 4*, Category A’ hotel, situated in Vravrona, Athens Greece. MARE NOSTRUM HOTEL  is located just 14 km from Eleftherios Venizelos airport and 38 km from Athens city center. More information regarding the Accommodation is available on the Meeting's website

read more
For more information please visit the Meeting's website
www.synuclein2017.org

Please feel free to contact the Meeting's P.C.O. Congress World, may you have any queries or if further clarifications are needed.
Professional Conference Organizer (P.C.O.) - Destination Management Company (D.M.C.)
Congress World
27, Michalakopoulou St., 115 28 Athens Greece
tel. +30 210 72 10 001, + 30 210 72 10 052
(Meeting's extension numbers 203 & 205)
email:  Maria Papapanagiotou  (mp@congressworld.gr)
         Michalis Gkoletsopoulos  (mg@congressworld.gr)
reception@congressworld.gr  |  info@congressworld.gr
unsubscribe